Article
Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming
28 Apr 2017
Abstract excerpt
Abstract Reprogramming adult, fully differentiated cells to pluripotency in vivo via Oct3/4 , Sox2 , Klf4 and c‐Myc (OSKM) overexpression has proved feasible in various independent studies and could be used to induce tissue regeneration owing to the proliferative capacity and differentiation potential of the reprogrammed cells. However, a number of these reports have described the generation of teratomas caused...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
